About PharmaVerse

At PharmaVerse, we believe innovative medicines should reach patients faster — with fewer barriers and stronger impact. 

Our vision is to be the trusted partner for life sciences companies at critical moments of growth, particularly providing biotech consulting in Australia as global biotechs expand into the market. We empower Australian medical leaders who require the agile capacity to deliver under pressure. 

By combining global biotech insight with deep knowledge of the Australian healthcare system, we act as an end-to-end partner across the product lifecycle - from registration and reimbursement to real-world evidence, access programs, and strategic communications, including effective healthcare access strategies. Whether shaping advisory boards, guiding medical strategy, or supporting promotional review, we help teams navigate complexity with clarity. 

We envision a future where Medical Affairs sits at the center of launch excellence — not just reviewing materials, but shaping evidence, integrating patient and clinician perspectives, and guiding cross-functional teams. By blending scientific insight with pragmatic execution, PharmaVerse provides comprehensive medical affairs solutions that help anticipate hurdles, accelerate decisions, and build the foundations for long-term success. 

In short: we close the gap between breakthrough science and real-world patient impact — whether you’re entering new markets or steering a local team through rising demands.

Sajni brings over 15 years of expertise in evidence synthesis, systematic reviews, and methodology design within the realm of biotech consulting in Australia. She is adept at illuminating areas of unmet need by utilizing evidence and scientific data to identify critical gaps and opportunities important for healthcare decision-making. Sajni excels at translating complex data into decision-ready outputs that inform funders, providers, policymakers, and governments, thereby enhancing healthcare access strategies. Her work underpins guidelines, education, and policy development, providing clients with the medical affairs solutions needed for effective access strategies.

Caroline has over 20 years of experience providing excellence in medical affairs and team leadership to pharmaceutical companies, including Eli Lilly, Novartis, and Sanofi, as well as serving as the Director of Markey Medical Consulting. Her expertise in biotech consulting in Australia encompasses specialty care and rare diseases across all stages of the product life cycle, from clinical trials to market access, launch preparedness, and medical education. Caroline excels in developing healthcare access strategies and leveraging KOL and patient insights to inform strategy and create innovative medical affairs solutions for delivering medicines.

Caroline brings over 30 years of experience in healthcare, including senior leadership roles at Pfizer, Roche, Bayer, TEVA, and CSIRO. She excels in biotech consulting in Australia, focusing on commercialisation, market research, healthcare access strategies, and go-to-market strategy, with expertise in areas such as oncology, ophthalmology, respiratory, and infectious disease. Renowned for her sharp commercial acumen and ability to create human connections, she guides teams in developing medical affairs solutions that effectively translate science into resonant strategies.

Tim is a senior pharmaceutical executive with extensive experience in general management, drug development, and commercial strategy across Australia, the US, and Europe. He has guided local sponsorship, R&D tax credits, and business development while focusing on healthcare access strategies and due diligence. His work includes commercialisation, go-to-market planning, access programs, reimbursement strategies, and field force planning. With expertise in transplant, immunology, oncology, and rare diseases, Tim offers biotech consulting in Australia and brings strategic insight to help clients navigate complex challenges and drive growth through effective medical affairs solutions.

Feisia brings over 15 years of experience in pharma, including roles at Pfizer and AstraZeneca as well as her consulting experience with Lucid MedComms. She specializes in medical communications and healthcare access strategies, focusing on omnichannel strategy and AI-driven solutions. These medical affairs solutions make clinical and regulatory data easier to use, share, and act on, empowering teams to deliver clear, compliant, and impactful content.

Jason brings over 15 years of experience in healthcare as a pharmacist, working directly with patients to understand their needs and how effective communication can support better health outcomes. He translates this expertise into the development of clear, compliant resources and company communications that connect patient needs with clinical practice. Additionally, Jason's specialization in biotech consulting Australia allows him to enhance healthcare access strategies and develop comprehensive medical affairs solutions. He prepares SOPs, reviews promotional materials, and creates resources for both healthcare professionals and patients. His approach ensures that pharmaceutical communications are relevant, effective, and enable companies to prioritize their strategic objectives.

With a background in medical lab science and research, Josephine specializes in translating complex data into accessible medical education and scientific resources. Her expertise spans diagnostics, renal, and cardiology, making her a valuable asset in biotech consulting in Australia. She is passionate about simplifying the complex for clinicians and patients — creating content that educates, engages, and drives adherence, ultimately supporting effective healthcare access strategies and medical affairs solutions.